ATE464038T1 - Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase - Google Patents

Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase

Info

Publication number
ATE464038T1
ATE464038T1 AT03756039T AT03756039T ATE464038T1 AT E464038 T1 ATE464038 T1 AT E464038T1 AT 03756039 T AT03756039 T AT 03756039T AT 03756039 T AT03756039 T AT 03756039T AT E464038 T1 ATE464038 T1 AT E464038T1
Authority
AT
Austria
Prior art keywords
rna
stranded rna
topical application
double stranded
rna oligonucleotide
Prior art date
Application number
AT03756039T
Other languages
English (en)
Inventor
Albert Duranton
Christine Collin-Djangone
Francis Pruche
Jean-Thierry Simonnet
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0206796A external-priority patent/FR2840217B1/fr
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE464038T1 publication Critical patent/ATE464038T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
AT03756039T 2002-06-03 2003-06-02 Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase ATE464038T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0206796A FR2840217B1 (fr) 2002-06-03 2002-06-03 Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations
US38672002P 2002-06-10 2002-06-10
PCT/FR2003/001648 WO2003101376A2 (fr) 2002-06-03 2003-06-02 Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna)

Publications (1)

Publication Number Publication Date
ATE464038T1 true ATE464038T1 (de) 2010-04-15

Family

ID=29713354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756039T ATE464038T1 (de) 2002-06-03 2003-06-02 Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase

Country Status (8)

Country Link
EP (1) EP1513482B1 (de)
JP (1) JP4499554B2 (de)
AT (1) ATE464038T1 (de)
AU (1) AU2003255621A1 (de)
CA (1) CA2485111A1 (de)
DE (1) DE60332112D1 (de)
ES (1) ES2342826T3 (de)
WO (1) WO2003101376A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
GB0307914D0 (en) * 2003-04-07 2003-05-14 Univ Dundee Cytochrome p450
US20080207545A1 (en) * 2003-10-21 2008-08-28 Hoke Glenn D Methods and Compositions for Treating 5Alpha-Reductase Type 1 and Type 2 Dependent Conditions
DE102004025881A1 (de) 2004-05-19 2006-01-05 Beiersdorf Ag Oligoribonukleotide zur Beeinflussung des Haarwachstums
WO2006040447A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de traitement cosmétique des fibres kératiniques et utilisation d'un inhibiteur de transglutaminase
WO2006040446A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de mise en forme de fibres kératiniques
US9139850B2 (en) 2005-05-19 2015-09-22 L'oreal Vectorization of dsRNA by cationic particles and topical use
FR2885808B1 (fr) * 2005-05-19 2007-07-06 Oreal Vectorisation de dsrna par des particules cationiques et utilisation topique.
FR2885813B1 (fr) * 2005-05-19 2008-01-11 Oreal Vectorisation de dsrna par des particules cationiques et leur utilisation sur modele de peau.
FR2890859B1 (fr) 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
JP4981381B2 (ja) * 2006-08-04 2012-07-18 株式会社ナリス化粧品 美白用皮膚外用剤
JP2008115101A (ja) * 2006-11-02 2008-05-22 Naris Cosmetics Co Ltd 美白用皮膚組成物
TWI382849B (zh) * 2007-10-29 2013-01-21 Mello Biotech Taiwan Co Ltd 產生藉由基因靜默效應以用於皮膚維護之化妝品的方法以及編碼基因靜默效應物之基因重組核苷酸
FR2940977B1 (fr) * 2009-01-13 2016-11-18 Oreal Utilisation de formes complexes de la proteine de type calmodulin-like skin protein clsp
FR2986233B1 (fr) * 2012-02-01 2014-02-28 Regentis Internat Peptide bifonctionnel
FR3043695B1 (fr) 2015-11-17 2019-10-25 ISP Investments LLC. Procede d'obtention d'un extrait aqueux enrichi en petits arn a partir d'une matiere vegetal et extraits issus du procede
FR3106754B1 (fr) 2020-02-04 2022-01-07 Isp Investments Llc Procede d’obtention d’un extrait aqueux de lavande, compositions comprenant un tel extrait et leurs utilisations cosmetiques
US20230167448A1 (en) * 2020-04-03 2023-06-01 Medrx Co., Ltd. Double Stranded RNA Specifically Inhibiting Expression of IL-23 and Pharmaceutical Composition Comprising Same
FR3116438B1 (fr) 2020-11-23 2022-10-14 Isp Investments Llc Procede d’obtention d’extraits aqueux de feuilles de thes, compositions comprenant de tels extraits et leurs utilisations cosmetiques
FR3125425A1 (fr) 2021-07-22 2023-01-27 Isp Investments Llc Extrait de feuilles de the noir, compositions le comprenant et ses utilisations cosmetiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927444D0 (en) * 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
FR2804960B1 (fr) * 2000-02-11 2005-06-24 Lvmh Rech Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase- related-protein 1 comme agents depigmentants

Also Published As

Publication number Publication date
WO2003101376A2 (fr) 2003-12-11
AU2003255621A1 (en) 2003-12-19
AU2003255621A8 (en) 2003-12-19
CA2485111A1 (fr) 2003-12-11
DE60332112D1 (de) 2010-05-27
WO2003101376A3 (fr) 2004-05-06
EP1513482B1 (de) 2010-04-14
ES2342826T3 (es) 2010-07-15
JP2005530812A (ja) 2005-10-13
EP1513482A2 (de) 2005-03-16
JP4499554B2 (ja) 2010-07-07

Similar Documents

Publication Publication Date Title
ATE464038T1 (de) Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase
IL160000A0 (en) Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory disease
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
AU2002311903A1 (en) Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
FR2842201B1 (fr) Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
FR2819403B1 (fr) Compositions cosmetiques contenant un fructane, un polysaccharide et un agent benefique et leurs utilisations
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
HK1070004A1 (en) Methods for treating rosacea and telangiectasia
HUP0101463A2 (hu) Olívaolajat és mézet tartalmazó anyagkeverék helyi alkalmazásra
AU2002258066A1 (en) Dermatological and cosmetic compositions
BRPI0508137A (pt) composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
DE60104901D1 (de) Hydroverfahrenskatalysator und dessen anwendung
ATE508731T1 (de) Haarbehandlungszusammensetzungen, die haarvolumen verleihen und die druckemfpindliche silikon- kleber enthalten
DK1294413T3 (da) Spröjtbare sammensætninger til sårpleje
MXPA05012753A (es) Composiciones cosmeticas estables que comprenden un agente autobronceador.
DE60106265D1 (de) Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor
DE60312211D1 (de) Haarbehandlungsmittel
NI200300045A (es) Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa.
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
WO2001066101A3 (en) Treatment of psoriasis
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
EP1546377A4 (de) Verfahren und zusammensetzungen zur behandlung von schmerzen und schmerzhaften erkrankungen unter verwendung von 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 oder 13424 molekülen
FR2819412B1 (fr) Composition cosmetique irisee et ses utilisations
AR036253A1 (es) Reduccion del crecimiento del vello
DE60305300D1 (de) Haarbehandlungszusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties